Alpha-2-Glycoprotein 1(AZGP1) Regulates Biological Behaviors of LoVo Cells by Down-Regulating mTOR Signaling Pathway and Endogenous Fatty Acid Synthesis

Prognostic role of serum AZGP1, PEDF and PRDX2 in colorectal cancer patients

(2013) Dengbo Ji et al.   CARCINOGENESIS

Decreased Expression of AZGP1 Is Associated with Poor Prognosis in Primary Gastric Cancer

(2013) Chun-yu Huang et al.   PLoS One

ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis

(2012) Trude H Ågesen et al.   GUT

Body Mass Index and Risk of Colorectal Cancer According to Fatty Acid Synthase Expression in the Nurses’ Health Study

(2012) Aya Kuchiba et al.   JNCI-Journal of the National Cancer Institute

Decreased expression of zinc-alpha2-glycoprotein in hepatocellular carcinoma associates with poor prognosis

(2012) Yan Huang et al.   Journal of Translational Medicine

The “HER2–PI3K/Akt–FASN Axis” Regulated Malignant Phenotype of Colorectal Cancer Cells

(2012) Nan Li et al.   LIPIDS

Low AZGP1 expression predicts for recurrence in margin-positive, localized prostate cancer

(2011) Po Yee Yip et al.   PROSTATE

Zinc-α2-glycoprotein: an adipokine modulator of body fat mass?

(2010) C Bing et al.   INTERNATIONAL JOURNAL OF OBESITY

AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-β-mediated ERK signaling

(2010) B Kong et al.   ONCOGENE

Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells

(2009) Thomas W. Grunt et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The adipokine zinc-α2-glycoprotein (ZAG) is downregulated with fat mass expansion in obesity

(2009) T. Mracek et al.   CLINICAL ENDOCRINOLOGY

Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer

(2009) Toshiro Migita et al.   JNCI-Journal of the National Cancer Institute

Zinc  2-Glycoprotein: A Multidisciplinary Protein

(2008) Md. I. Hassan et al.   MOLECULAR CANCER RESEARCH